Estrella Immunopharma, Inc. Common Stock

ESLANASDAQ • USD
ThemeHealthcare - Oncology›Cell & Gene Therapy for Cancer
1.14 USD
↘ 0.01 (0.87%)AT CLOSE (11:59 AM EDT)
1.12
↘ 0.02 (1.75%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.12
↘ 0.02 (1.75%)
🔴Market: CLOSED
Open?$1.15
High?$1.15
Low?$1.10
Prev. Close?$1.15
Volume?6.7K
Avg. Volume?38.6K
VWAP?$1.13
Rel. Volume?0.17x
Bid / Ask
Bid?$0.95 × 100
Ask?$1.36 × 100
Spread?$0.41
Midpoint?$1.15
Valuation & Ratios
Market Cap?49.1M
Shares Out?43.0M
Float?10.2M
Float %?27.1%
P/E Ratio?N/A
P/B Ratio?-9.31
EPS?-$0.31
Dividend?0.00%
Ex-Dividend?N/A

ESLA is currently priced at $1.14. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (251.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Themes
Healthcare - Oncology›Cell & Gene Therapy for Cancer
Employees
N/A
Market Cap
49.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.estrellabio.com
Listed
2023-10-02
Address
5858 HORTON STREET, SUITE 370
EMERYVILLE, CA 94608
Phone: (510) 318-9098
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
74
Piotroski F-Score?0/9Weak
Altman Z-Score?-25.92Distress
Confidence?39%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.92%Low
Short Interest?94.1K
Days to Cover?2.7
Free Float10.2M
Avg Daily Volume35.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?0.24Weak
Quick Ratio?0.24Weak
Cash Ratio?0.22Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-9.31CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-3.6CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
251.4%STRONG▾
ROA?
S&P
3
-362.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$47.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist